Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Autoimmune Hepatitis in Small Cell Lung Cancer-A Case Report].
Kondo N, Kitagawa S, Yamamoto M, Yamamoto R, Abe T, Watabe H, Watanabe Y, Fujiwara T, Tominaga S, Natsume I, Sakashita H, Aida S. Kondo N, et al. Among authors: sakashita h. Gan To Kagaku Ryoho. 2020 Jun;47(6):963-965. Gan To Kagaku Ryoho. 2020. PMID: 32541175 Japanese.
[Cancer stem cell].
Sakashita H, Ieta K, Haraguchi N, Inoue Y, Yoshizawa Y, Mori M. Sakashita H, et al. Gan To Kagaku Ryoho. 2007 Nov;34(11):1721-9. Gan To Kagaku Ryoho. 2007. PMID: 18030004 Review. Japanese.
[A Case of Pulmonary Enteric Adenocarcinoma with Soleus Muscle Metastasis].
Suzuki T, Furusawa H, Watanabe Y, Sakashita H, Fujii S, Tasaka Y, Shimada S, Majima H, Kawahara T, Katayanagi S, Ejima M, Nukui Y, Shirai T, Masuo M, Tateishi T, Fujie T, Tamaoka M, Taguchi T, Tomii S, Miyazak Y. Suzuki T, et al. Among authors: sakashita h. Gan To Kagaku Ryoho. 2019 Feb;46(2):267-270. Gan To Kagaku Ryoho. 2019. PMID: 30914531 Japanese.
The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease.
Nishiyama N, Honda T, Sema M, Kawahara T, Jin Y, Natsume I, Chiaki T, Yamashita T, Tsukada Y, Taki R, Miyashita Y, Saito K, Tateishi T, Sakashita H, Miyazaki Y. Nishiyama N, et al. Among authors: sakashita h. Int J Clin Oncol. 2020 Feb;25(2):282-291. doi: 10.1007/s10147-019-01576-x. Epub 2019 Nov 13. Int J Clin Oncol. 2020. PMID: 31720993
Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease.
Tasaka Y, Honda T, Nishiyama N, Tsutsui T, Saito H, Watabe H, Shimaya K, Mochizuki A, Tsuyuki S, Kawahara T, Sakakibara R, Mitsumura T, Okamoto T, Kobayashi M, Chiaki T, Yamashita T, Tsukada Y, Taki R, Jin Y, Sakashita H, Natsume I, Saitou K, Miyashita Y, Miyazaki Y. Tasaka Y, et al. Among authors: sakashita h. Lung Cancer. 2021 May;155:120-126. doi: 10.1016/j.lungcan.2021.03.014. Epub 2021 Mar 22. Lung Cancer. 2021. PMID: 33798901
A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).
Sakashita H, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita T, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y. Sakashita H, et al. Thorac Cancer. 2022 May;13(9):1267-1275. doi: 10.1111/1759-7714.14376. Epub 2022 Mar 23. Thorac Cancer. 2022. PMID: 35322551 Free PMC article. Clinical Trial.
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Minegishi Y, Akagami T, Arai M, Saito R, Arai D, Murase K, Miura K, Watanabe S, Sakashita H, Miyabayashi T, Honda R, Jingu D, Hotta T, Isobe K, Nakazawa K, Ito K, Takamura K, Inomata M, Harada T, Sakakibara R, Nakagawa T, Shibuya H, Takenaka K, Kobayashi K, Seike M. Minegishi Y, et al. Among authors: sakashita h. Lung Cancer. 2022 Oct;172:1-8. doi: 10.1016/j.lungcan.2022.07.009. Epub 2022 Jul 26. Lung Cancer. 2022. PMID: 35952438 Review.
Alectinib for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401).
Iwama E, Goto Y, Murakami H, Harada T, Tsumura S, Sakashita H, Mori Y, Nakagaki N, Fujita Y, Seike M, Bessho A, Ono M, Okazaki A, Akamatsu H, Morinaga R, Ushijima S, Shimose T, Tokunaga S, Hamada A, Yamamoto N, Nakanishi Y, Sugio K, Okamoto I. Iwama E, et al. Among authors: sakashita h. J Thorac Oncol. 2017 Jul;12(7):1161-1166. doi: 10.1016/j.jtho.2017.02.012. Epub 2017 Feb 24. J Thorac Oncol. 2017. PMID: 28238961 Free article. Clinical Trial.
241 results